BiotechTube
Home/Soleno Therapeutics/Anish Bhatnagar, MD
AB

Anish Bhatnagar, MD

Chairman of the Board and Chief Executive Officer

Soleno Therapeutics

Therapeutic Areas

Rare Genetic DisordersGenetic Obesity DisordersPrader-Willi Syndrome

Soleno Therapeutics Pipeline

DrugIndicationPhase
VYKAT XR (setmelanotide)Hyperphagia in Prader-Willi SyndromeMarketed
SetmelanotideBardet-Biedl Syndrome / Alström SyndromePhase 3

Leadership Team at Soleno Therapeutics

LB
Lauren Budesheim
Senior Vice President, People
NM
Neil M. Cowen, PhD, MBA
Senior Vice President, New Product Planning
DC
Dawn Carter Bir
Board Member
MH
Mark Hahn
Board Member
View full Soleno Therapeutics profile